Press Releases

Questions? +1 (732) 747-1007
ir@americancryostem.com

Physicians
Licensing & Partners

SERVICES
PRODUCTS
OUR SCIENCE
- LONG COVID CLINICAL TRIAL
INVESTORS
NEWS
CONTACT

CRYO Public Announcements

Press Releases

About American CryoStem Corporation

American CryoStem Corporation (OTC:CRYO), is a clinical-stage biotechnology company, global licensor and a pioneer in autologous (one’s own) cellular processing and therapies. The Company's centralized laboratory model and patented foundational “CryoStem Platform” is a best-in-class, end-to-end cellular therapy solution to treat injuries, disorders and chronic diseases through a single adipose-tissue (fat) harvest and ATCELLBank™ cryopreservation. We are dedicated to helping the world’s physicians, hospitals, and clinics improve clinical outcomes by developing and delivering effective leading-edge stem cell therapies that improve patient health and quality of life.

Physicians
Licensing & Partners